Delivery Order SPE2DB20D9329-SPE2DB22FD4GG
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $24,872.20, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order falls under a larger single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The firm fixed-price contract, valued at $29,846.64, is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products to support the recurring medical supply needs of military health facilities. This order is placed under a larger single-award indefinite delivery contract (IDC) between DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $24,872.20, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,846.64, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to $499,999,999...
- This is a $27,359.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4565029494 - EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance through July 18, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,928.66 award is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, with a completion date of March 31, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,531.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,510.63, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,378.70 order is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military health facilities. The order is placed under a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract is valued at $14,923.32 and has a completion date of May 22, 2024. It is not associated with a set-aside program. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FD4GGDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $29,087.52, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is issued under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.1k | 1/26/22 |